Targeting phosphodiesterase 3A: discovery of a promising cancer therapy

Harri Sihto, Katja Ivanitskiy, Olli Kallioniemi

Forskningsoutput: TidskriftsbidragArtikelVetenskaplig

Sammanfattning

A new promising sarcoma target, phosphodiesterase 3A (PDE3A), and drugs targeting it have been identified by researchers at the University of Helsinki. Dr Katja Ivanitskiy, Dr Harri Sihto and Professor Olli Kallioniemi outline emerging evidence that indicates PDE3A protein-targeting compounds may induce sarcoma cell death by acting as a molecular glue between PDE3A and Schlafen 12 proteins.
Originalspråkengelska
TidskriftDrug target review
Volym8
Nummer2
Sidor (från-till)57-59
Antal sidor3
ISSN2059-1349
StatusPublicerad - 22 juni 2021
MoE-publikationstypB1 Artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

  • 3122 Cancersjukdomar

Citera det här